Top Industry Leaders in the Lab-on-a-Chip Device Market
Cellairis Biomarkers Signed a collaboration agreement with AstraZeneca to develop and commercialize LOC-based assays for biomarker discovery and validation in oncology research.
Dolomite Microfluidics Launched the µFLUX Prime™ microfluidic workstation, offering a flexible and user-friendly platform for rapid prototyping and development of LOCs.
Emulate Expanded its Organ-on-a-Chip technology platform with the launch of the Emulate Lung-Chip™ model, providing researchers with a realistic model to study lung diseases and drug responses.
Abbott Laboratories Received FDA approval for its i-STAT Alinity CL system, featuring LOC technology for rapid blood gas and electrolyte testing in point-of-care settings.
Roche Diagnostics Introduced the cobas® EGFR Mutation Test on its cobas® m500 system, utilizing LOC technology for rapid and efficient detection of EGFR mutations in cancer patients.
List of Lab-on-a-Chip Device Key Companies in the Market
- Becton, Dickinson and Company
- Agilent Technologies Inc.
- Danaher Corporation
- Bio-Rad Laboratories
- Abbott Laboratories
- Hoffmann-La Roche AG
- PerkinElmer Inc.
- IDEX Corporation
- Thermo Fisher Scientific Inc.
- Cepheid Inc.
- Biacore AB